Genitourinary Cancers Symposium Media Resource Center
The embargo on all abstracts part of the 2016 Genitourinary Cancers Symposium will lift at 5:00 PM ET on Monday, January 4, 2016. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on January 4 for credentialed media.
Attend the Meeting in Person/Participate in the Presscast
ASCO's Media Headquarters is where you can apply for media credentials*, register to attend an upcoming meeting, access embargoed meeting information, and locate presscast dial-in information. For questions about how to navigate the site, please contact firstname.lastname@example.org.
*If you attended the 2015 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information and the presscast. You only have to register if you want to attend the Symposium in San Francisco.
Access Embargoed Information
Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.
2016 Symposium Highlights Notable Research Advances in Genitourinary Cancers
SAN FRANCISCO - Eight studies exploring key issues in the treatment of genitourinary cancers will be presented at the 2016 Genitourinary Cancers Symposium, taking place January 7-9 at the Moscone West Building in San Francisco. Read the full release.
Cabozantinib Improves Upon the Standard of Care for Advanced Kidney Cancer
ALEXANDRIA, Va. – New analyses from a phase III clinical trial of patients with previously treated advanced kidney cancer demonstrated that patients of all risk levels experience more benefit from cabozantinib than from the current standard of care everolimus. Read the full release.
Regular Aspirin Use May Reduce Risk of Dying From Prostate Cancer
ALEXANDRIA, Va. – A large observational study has found that men who take aspirin regularly may have a lower risk of dying from prostate cancer. Read the full release.
New Blood Test Technology Shows Promise for Guiding Prostate Cancer Treatment Decisions
ALEXANDRIA, Va. – An early study suggests that an experimental new blood test may help guide individualized decisions on the most appropriate treatments for patients with prostate cancer. Read the full release.
2016 Genitourinary Cancers Symposium Press Program to Feature Research Advances in Prostate and Kidney Cancers
ALEXANDRIA, Va. – Co-sponsors of the 2016 Genitourinary Cancers Symposium announced today three abstracts that will be highlighted in the meeting’s official Press Program. Read the full release.